Tenax Therapeutics’ management will also participate in one-on-one investor meetings. To request a one-on-one meeting at the conference, please contact your Guggenheim representative. The live and ...

Tenax Therapeutics (TENX) announced the appointment of Gillian Andor, MSc, as Vice President, Clinical Operations. Andor will lead the Company’s expanding Clinical Operations function in support ...

Tenax Therapeutics focuses on addressing cardiovascular and pulmonary diseases with high unmet medical needs. Besides levosimendan, the company may resume developing its oral formulation of imatinib.

Tenax Therapeutics also announced the issuance on January 21, 2025 of an inducement equity award to Ms. Andor in connection with her appointment to the position of Vice President, Clinical ...

Tenax Therapeutics’ management will also participate in one-on-one investor meetings. To request a one-on-one meeting at the conference, please contact your Guggenheim representative.